U.S. market Closed. Opens in 17 hours 13 minutes

RIGL | Rigel Pharmaceuticals, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-311999-12-31
Revenue116.88M120.24M149.24M108.62M59.29M44.51M4.48M20.38M28.89M8.25M7.15M2.25M4.75M125.00M750.00KN/A12.60M33.47M16.53M4.73M11.05M15.79M15.30M13.22M8.98M
Cost of Revenue7.11M1.75M1.08M895.00K906.00K287.00KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A-7.56M-1.91M
Gross Profit109.77M118.49M148.15M107.73M58.38M44.22MN/AN/A28.89M8.25M7.15M2.25M4.75M125.00M750.00KN/A12.60M33.47M16.53M4.73M11.05M15.79M15.30M20.77M10.89M
Operating Expenses130.26M172.72M157.13M136.70M127.47M116.91M84.10M84.35M80.64M99.50M94.94M101.63M91.12M89.68M111.65M136.71M92.13M76.52M64.45M61.60M51.88M52.80M40.26M46.28M22.97M
Selling, General & Admin105.74M112.45M91.89M76.60M74.59M70.00M37.83M20.91M17.81M31.80M19.61M22.85M21.77M25.29M20.90M27.04M21.76M19.55M12.41M13.08M8.52M9.45M7.95M6.69M3.95M
Research & Development24.52M60.27M65.24M60.10M52.88M46.90M46.27M63.45M62.83M67.70M75.33M78.78M69.35M64.39M90.74M109.67M70.36M56.97M52.04M48.52M43.36M43.35M32.31M32.03M17.11M
Other Operating ExpensesN/A1.32M3.52MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A7.56M1.91M
Operating Income-20.49M-54.23M-8.97M-28.97M-69.09M-72.68M-79.62M-63.97M-51.74M-91.25M-87.79M-99.38M-86.37M35.32M-110.90M-136.71M-79.53M-43.05M-47.92M-56.87M-40.83M-37.02M-24.96M-25.50M-12.08M
Other Expenses / Income-4.60M-4.34M-8.33M-771.00K2.20M2.20M1.62M-5.25M279.00K341.00K-1.24M537.00K395.00K2.57M-744.00K4.28MN/AN/AN/A-30.00K-169.00KN/AN/AN/AN/A
Before Tax Income-25.09M-58.57M-17.31M-29.74M-66.89M-70.48M-77.99M-69.22M-51.46M-90.91M-89.03M-98.84M-85.97M37.89M-111.64M-132.44MN/AN/AN/AN/AN/AN/AN/AN/AN/A
Income Tax Expenses2.27M3.02M605.00K647.00K-348.00K2.20MN/AN/AN/AN/AN/AN/AN/AN/A-93.00K-89.00KN/AN/AN/AN/AN/AN/AN/AN/AN/A
Net Income-25.09M-61.60M-17.91M-30.39M-66.55M-70.48M-77.99M-69.22M-51.46M-90.91M-89.03M-98.84M-85.97M37.89M-111.55M-132.35M-74.27M-37.64M-45.26M-56.26M-41.20M-37.03M-23.80M-25.36M-12.37M
Interest Expenses6.87M3.71M4.86M1.35M335.00KN/AN/AN/AN/AN/AN/AN/A25.00K91.00K203.00K160.00K221.00K290.00K276.00K324.00K575.00K870.00K802.00K933.00KN/A
Basic Shares Outstanding174.02M172.41M170.49M168.75M167.40M160.53M126.32M94.39M88.43M87.66M87.29M74.97M63.33M52.05M40.88M36.02M28.94M24.94M21.86M18.05M11.39M4.99M4.14M806.92K34.79K
Diluted Shares Outstanding174.02M172.41M170.49M168.75M167.40M160.53M126.32M94.39M88.43M87.66M87.29M74.97M63.33M52.57M40.88M36.02M28.94M24.94M21.86M18.05M11.39M4.99M4.14M806.92K34.79K
EBITDA-16.98M-53.55M-8.93M-28.39M-66.56M-72.68M-77.53M-68.28M-50.02M-88.55M-86.44M-96.41M-83.99M39.30M-110.03M-135.29M-72.71M-35.93M-43.80M-53.56M-37.45M-30.34M-16.24M-16.87M-10.46M
EBITDA Margin-14.53%-44.53%-5.98%-26.14%-112.26%-163.30%-1,728.97%-334.96%-173.13%-1,073.32%-1,208.88%-4,284.76%-1,768.27%31.44%-14,671.20%0.00%-577.04%-107.34%-265.04%-1,131.59%-338.72%-192.15%-106.14%-127.63%-116.43%
EBIT-15.95M-54.87M-12.45M-28.39M-66.56M-68.28M-77.99M-69.22M-51.46M-90.91M-89.03M-98.84M-85.95M37.98M-111.44M-132.28M-74.05M-37.35M-44.98M-55.93M-40.62M-36.16M-23.00M-24.43M-12.37M
EBIT Margin-13.64%-45.63%-8.34%-26.14%-112.26%-153.40%-1,739.34%-339.58%-178.11%-1,101.92%-1,245.13%-4,392.89%-1,809.43%30.38%-14,858.27%0.00%-587.71%-111.57%-272.18%-1,181.72%-367.45%-229.03%-150.32%-184.80%-137.64%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-311999-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙